🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

University of California, San Francisco clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our India and China registers with University of California, San Francisco as lead sponsor. Synced 26 Sep 2026
7Current trials
4Recruiting now
1Drug in these trials
2Trial registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

University of California, San Francisco is the lead sponsor of 7 current clinical trials in our India and China registers. 4 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Cyclosporine A. The most-studied condition is Intimate Partner Violence.

ClinicalTrials.gov trials by status

  • Recruiting457%
  • Active, closed343%

Trials by phase

  • Not applicable457%
  • Phase 3229%
  • Observational114%
01

Clinical trials sponsored by University of California, San Francisco

7 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A
NCT06658002 · ClinicalTrials.gov ↗ · Fungal Keratitis, Corneal Ulcer
Phase 3 Recruiting 2025-09 India
mHealth India Postnatal Health Intervention Effectiveness
NCT05268588 · ClinicalTrials.gov ↗ · Health Knowledge, Attitudes, Practice, Post Partum Depression, Breastfeeding
Not applicable Recruiting 2025-01 India
Rapid Research in Diagnostics Development for TB Network
NCT04923958 · ClinicalTrials.gov ↗ · Tuberculosis
Not applicable Recruiting 2021-04 India
FDG PET/MRI Imaging of Patellofemoral Joint Osteoarthritis
NCT07625150 · ClinicalTrials.gov ↗ · Patellofemoral Osteoarthritis, Knee Osteoarthritis, Knee Pain
Observational Recruiting 2025-02 China
Harmony: A Combined MI and BCT Intervention to Reduce Intimate Partner Violence and Alcohol Use in South India
NCT05893277 · Intimate Partner Violence, Alcohol Use Disorder
Not applicable Active, closed 2023-10 India
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II
NCT06271772 · ClinicalTrials.gov ↗ · Bacterial Keratitis
Phase 3 Active, closed 2024-07 India
Group-based Life Skills and Health Empowerment for Married Women to Avoid Unintended Pregnancies in India
NCT06024616 · ClinicalTrials.gov ↗ · Pregnancy, Unplanned, Contraceptive Behavior
Not applicable Active, closed 2024-04 India

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in University of California, San Francisco trials

1 compound

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in University of California, San Francisco trials

16 conditions
Intimate Partner Violence1Alcohol Use Disorder1Bacterial Keratitis1Fungal Keratitis1Corneal Ulcer1Pregnancy, Unplanned1Contraceptive Behavior1Health Knowledge, Attitudes, Practice1Post Partum Depression1Breastfeeding1Nutrition, Healthy1Tuberculosis1Patellofemoral Osteoarthritis1Knee Osteoarthritis1Knee Pain1Inflamation1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in India63
Clinical trials in China11

A trial with sites in more than one country appears in each of those registers.

05

Questions about University of California, San Francisco trials

How many clinical trials does University of California, San Francisco sponsor?

University of California, San Francisco is the lead sponsor of 7 current trials on ClinicalTrials.gov in our India and China registers, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are University of California, San Francisco trials recruiting?

Yes. 4 of its 7 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is University of California, San Francisco testing?

Its current trials name 1 drug or biological as interventions. The most frequent are Cyclosporine A (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.